Terms: = Prostate cancer AND CEACAM5, CEA AND Treatment
80 results:
1. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
[No Abstract] [Full Text] [Related]
2. A novel exosome based therapeutic intervention against neuroendocrine prostate cancer.
Saini S; Sreekumar A; Nathani S; Asante DM; Simmons MN
Sci Rep; 2024 Feb; 14(1):2816. PubMed ID: 38307935
[TBL] [Abstract] [Full Text] [Related]
3. Observation of Serological Index and Efficacy of Abiraterone Hydrochloride Tablets Combined with Endocrine Therapy in Patients with Metastatic Castration-Resistant prostate cancer.
Yu L; Sun H; Che M; Gai W
Arch Esp Urol; 2023 Oct; 76(8):588-595. PubMed ID: 37960958
[TBL] [Abstract] [Full Text] [Related]
4. Tumour Marker Requisition Pattern in a Tertiary Care Centre of Eastern Nepal.
Niraula A; Gelal B; Chaudhari RK; Das BK; Lamsal M
Kathmandu Univ Med J (KUMJ); 2022; 20(80):422-426. PubMed ID: 37795716
[TBL] [Abstract] [Full Text] [Related]
5. The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine prostate cancer.
Van Emmenis L; Ku SY; Gayvert K; Branch JR; Brady NJ; Basu S; Russell M; Cyrta J; Vosoughi A; Sailer V; Alnajar H; Dardenne E; Koumis E; Puca L; Robinson BD; Feldkamp MD; Winkis A; Majewski N; Rupnow B; Gottardis MM; Elemento O; Rubin MA; Beltran H; Rickman DS
Cancer Res Commun; 2023 Aug; 3(8):1447-1459. PubMed ID: 37546702
[TBL] [Abstract] [Full Text] [Related]
6. Electrochemical aptasensor based on the engineered core-shell MOF nanostructures for the detection of tumor antigens.
Khan S; Cho WC; Sepahvand A; Haji Hosseinali S; Hussain A; Nejadi Babadaei MM; Sharifi M; Falahati M; Jaragh-Alhadad LA; Ten Hagen TLM; Li X
J Nanobiotechnology; 2023 Apr; 21(1):136. PubMed ID: 37101280
[TBL] [Abstract] [Full Text] [Related]
7. Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis.
Jiao B; Basu A
Pharmacoeconomics; 2023 Sep; 41(9):1065-1077. PubMed ID: 36877451
[TBL] [Abstract] [Full Text] [Related]
8. Recent Progress in Biosensors for Detection of Tumor Biomarkers.
Li M; Jiang F; Xue L; Peng C; Shi Z; Zhang Z; Li J; Pan Y; Wang X; Feng C; Qiao D; Chen Z; Luo Q; Chen X
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364157
[TBL] [Abstract] [Full Text] [Related]
9. Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence.
Weng X; Zhong L; Xiang P; Li Y; Paciorek A; Dong L; Broering J; Carroll PR; Sanda M; Wilson L
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13740. PubMed ID: 36239065
[TBL] [Abstract] [Full Text] [Related]
10. Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the prostate fractionated irradiation trial - PROFIT.
Zhou K; Renouf M; Perrocheau G; Magné N; Latorzeff I; Pommier P; Créhange G; Paumier A; Bera G; Martin J; Catton C; Bellanger M; Supiot S
Radiother Oncol; 2022 Aug; 173():306-312. PubMed ID: 35772576
[TBL] [Abstract] [Full Text] [Related]
11. Elevated serum cea is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB
Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303
[TBL] [Abstract] [Full Text] [Related]
12. A highly-specific fully-human antibody and CAR-T cells targeting CD66e/ceacam5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivo.
Baek DS; Kim YJ; Vergara S; Conard A; Adams C; Calero G; Ishima R; Mellors JW; Dimitrov DS
Cancer Lett; 2022 Jan; 525():97-107. PubMed ID: 34740610
[TBL] [Abstract] [Full Text] [Related]
13. Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy.
Al-Mansoori L; Elsinga P; Goda SK
Biomed Pharmacother; 2021 Dec; 144():112260. PubMed ID: 34607105
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive analysis in mucin-producing urothelial-type adenocarcinoma of the prostate: case study with literature review.
Moe K; Maa HC; Pei D; Liang YJ; Chen YL
Pol J Pathol; 2020; 71(3):244-253. PubMed ID: 33112115
[TBL] [Abstract] [Full Text] [Related]
15. Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment.
Vuijk FA; de Muynck LDAN; Franken LC; Busch OR; Wilmink JW; Besselink MG; Bonsing BA; Bhairosingh SS; Kuppen PJK; Mieog JSD; Sier CFM; Vahrmeijer AL; Verheij J; Fariňa-Sarasqueta A; Swijnenburg RJ
Sci Rep; 2020 Oct; 10(1):16211. PubMed ID: 33004930
[TBL] [Abstract] [Full Text] [Related]
16. Carbon dots-based fluorescence resonance energy transfer for the prostate specific antigen (PSA) with high sensitivity.
He JH; Cheng YY; Zhang QQ; Liu H; Huang CZ
Talanta; 2020 Nov; 219():121276. PubMed ID: 32887166
[TBL] [Abstract] [Full Text] [Related]
17. [
Kunikowska J; Cieślak B; Gierej B; Patkowski W; Kraj L; Kotulski M; Zieniewicz K; Królicki L
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):883-892. PubMed ID: 32885272
[TBL] [Abstract] [Full Text] [Related]
18. Tumour markers and their utility in imaging of abdominal and pelvic malignancies.
Lahoud RM; O'Shea A; El-Mouhayyar C; Atre ID; Eurboonyanun K; Harisinghani M
Clin Radiol; 2021 Feb; 76(2):99-107. PubMed ID: 32861463
[TBL] [Abstract] [Full Text] [Related]
19. [A Case of Long-Term Clinical Complete Response after Chemotherapy for Locally Advanced Rectal cancer].
Kikuchi I; Abe T; Kurihara Y; Hayashi K; Kimura T; Shimbo T; Wakabayashi T; Ota S; Sato T; Itoh S
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2437-2439. PubMed ID: 32156957
[TBL] [Abstract] [Full Text] [Related]
20. Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer.
Qi L; Liu S; Jiang Y; Lin JM; Yu L; Hu Q
Anal Chem; 2020 Mar; 92(5):3867-3873. PubMed ID: 32069024
[TBL] [Abstract] [Full Text] [Related]
[Next]
